CASE REPORT
Marfan syndrome – typical musculoskeletal abnormalities, rare occurrence in children
More details
Hide details
Submission date: 2014-10-22
Final revision date: 2014-11-11
Acceptance date: 2014-11-13
Online publication date: 2014-11-30
Publication date: 2014-12-31
Reumatologia 2014;52(6):402-405
KEYWORDS
TOPICS
ABSTRACT
Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder. It is caused by a mutation in the fibrillin-1 (FBN1) gene located on chromosome 15 as a result of activation of transforming growth factor . Since MFS affects most organs and tissues, patients with this disease constitute a clinically heterogeneous group. Specifically, MFS affects and causes disorders of the musculoskeletal system, eyes, heart and large blood vessels. A poor prognosis is expected due to the high risk of cardiovascular and ocular complications, which are caused by progressive dilatation of the aorta and ectopia lentis.
This article describes a case of MFS with typical musculoskeletal abnormalities.
REFERENCES (18)
1.
Lipscomb KJ, Clayton-Smith J, Harris R. Evolving phenotype of Marfan’s syndrome. Arch Dis Child 1997; 76: 41-46. .
2.
Staufenbiel I, Hauschild Ch, Kahl-Nieke B, et al. Periodontal conditions in patients with Marfan syndrome – a multicenter case control study. BMC Oral Health 2013; 13: 59. .
3.
Zimmermann-Górska I. Nadmierna ruchomość stawów a choroby reumatyczne. Reumatologia 2007; 45: 397-403. .
4.
Chiu HH, Wu MH, Chen HC. Epidemiological profile of Marfan syndrome in a general population: a national database study. Mayo Clin Proc 2014; 89: 34-42. .
5.
Wypasek E, Potaczek DP, Stąpor R, et al. First report of the genetic background of Marfan syndrome in Polish patients. Pol Arch Med Wewn 2013; 123: 646-647. .
6.
Hoffjan S. Genetic Dissection of Marfan Syndrome and Related Connective Tissue Disorders: An Update 2012. Molecular Syndromology 2012; 3: 47-58. .
7.
Benke K, Ágg B, Szilveszter B, et al. The role of transforming growth factor-beta in Marfan syndrome. Cardiol J 2013; 20: 227-234. .
8.
Szydłowski L, Pucicka-Hoffmann K, Smoleńska-Petelenz J, Krzystolik-Ładzińska J. Clinical investigation and echocardiography value in accuracy of Marfan’s syndrome diagnosis. Pediatr Med Rodz 2009; 5: 264-270. .
9.
DePaepe A, Deitz HC, Devereux RB, et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62: 417-426 .
10.
Gray JR, Davies SJ. Marfan syndrome. J Med Genet 1996; 33: 403-408. .
11.
Kaissi Al A, Zwettler E, Ganger R, et al. Musculo-skeletal abnormalities in patients with Marfan syndrome. Clin Med Insights Arthritis Musculoskelet Disord 2013; 6: 1-9. .
12.
Laffargue F, Lienhardt-Roussie A, Lacombe D, Delrue MA. Clinical signs of Marfan syndrome in children under 10 years of age. Arch Pediatr 2013; 20: 1193-1200. .
13.
Dean J. Marfan syndrome: clinical diagnosis and management. Eur J Hum Genet 2007; 15: 724-733. .
14.
Lopez R, Berg-McGraw J. Marfan syndrome in a female collegiate basketball player: a case report. J Athl Train 2000; 35: 91-95. .
15.
Datta S, Datta H. Subluxation of lens in Marfan syndrome. Indian Pediatr 2009; 46: 434. .
16.
Raanani E, Ghosh P. The multidisciplinary approach to the Marfan patient. Ir Med Assoc J 2008; 10: 171-174. .
17.
Shi-Min Yuan, Hua Jing. Marfan’s syndrome: an overview. Sao Paulo Med J 2010: 128: 360-366. .
18.
Bergman R, Nevet MJ, Gescheidt-Shoshany H. Atrophic skin patches with abnormal elastic fibers as a presenting sign of the MASS phenotype associated with mutation in the fibrillin 1 gene. JAMA Dermatol 2014; 150: 885-889.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.